Fighting Covid-19: A pharmacist displays a box of dexamethasone at the Erasme Hospital amid the coronavirus disease outbreak, in Brussels, Belgium. A large, randomised trial in the UK that compared dexamethasone - a generic steroid - to standard treatment found that the drug cut the risk of death in severely ill patients. — Reuters
AS Covid-19 cases and hospitalisations continue to rise in the US and other parts of the world, Oxford University scientists provided a much-needed piece of good news Tuesday:
A large, randomised trial in the UK that compared dexamethasone - a generic steroid - to standard treatment found that the drug cut the risk of death in severely ill patients.
The result comes with caveats.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
